[1] Raggi P.
Cardiovascular disease: coronary artery calcification predicts risk of CVD in
patients with CKD[J].Nat Rev Nephrol,2017,13(6):324-326. DOI:10.1038/nrneph.2017.61.
[2] 陈洁,陈妙,应一樱,等. 冠状动脉钙化积分对于透析患者心血管事件发生风险的预测价值[J]. 中华全科医学,2019,17(11):1856-1859.
DOI:10.16766/j.cnki.issn.1674-4152. 001074.
[3] Thomas IC, Forbang NI, Criqui MH. The
evolving view of coronary artery calcium and cardiovascular disease
risk[J].Clin Cardiol,2018,41(1):144-150. DOI:10.1002/clc.22842.
[4] Levey AS, Coresh J. Chronic kidney
disease[J].Lancet,2012,379(9811):165-180. DOI:10.1016/S0140-6736(11)60178-5.
[5] Tanaka K, Watanabe T, Takeuchi A, et al.
Cardiovascular events and death in Japanese patients with chronic kidney
disease[J].Kidney Int,2017,91(1):227-234. DOI:10.1016/j.kint.2016.09.015.
[6] Anaya P, Blomquist GA, Davenport DL, et
al. Coronary artery calcification in CKD-5D patients is tied to adverse cardiac
function and increased mortality[J].Clin Nephrol,2016(12):291-302.
DOI:10.5414/CN108940.
[7] Horbal SR, Rossman AH, Brown E, et al.
Morphomic calcification score from clinical CT scans: a proxy for coronary
artery calcium[J].Clin Imaging,2020,66:57-63.
DOI:10.1016/j.clinimag.2020.03.017.
[8] 张昕,郝晓光. CT冠状动脉钙化评分与慢性肾脏病患者心血管事件风险的相关性[J]. 中国药物与临床,2020,20(3):333-337. DOI:10.11655/zgywylc2020.03.001.
[9] Agatston AS, Janowitz WR, Hildner FJ, et
al. Quantification of coronary artery calcium using ultrafast computed
tomography[J].J Am Coll Cardiol,1990,15(4):827-832.
DOI:10.1016/0735-1097(90)90282-t.
[10] Callister TQ, Cooil B, Raya SP, et al.
Coronary artery disease: improved reproducibility of calcium scoring with an
electron-beam CT volumetric method[J].Radiology,1998,208(3):807-814.
DOI:10.1148/radiology.208. 3.9722864.
[11] Hong C, Becker CR, Schoepf UJ, et al.
Coronary artery calcium: absolute quantification in nonenhanced and
contrast-enhanced multi-detector row CT
studies[J].Radiology,2002,223(2):474-480. DOI:10.1148/radiol. 2232010919.
[12] Bundy JD, Cai X, Scialla JJ, et al.
Serum calcification propensity and coronary artery calcification among patients
with CKD: the CRIC (Chronic Renal Insufficiency Cohort) study[J].Am J Kidney
Dis,2019,73(6):806-814. DOI:10.1053/j.ajkd.2019.01.024.
[13] 王诚明,成官迅,端木一博. 双源CT评价冠状动脉钙化与慢性肾疾病的相关性[J]. 实用医学杂志,2016,32(4):621-624.
DOI:10.3969/j.issn.1006-5725.2016.04.035.
[14] Su X, Zhang K, Guo F, et al.
Ischemia-modified albumin, a predictive marker of major adverse cardiovascular
events in continuous ambulatory peritoneal dialysis patients[J].Clin
Biochem,2013,46(15):1410-1413. DOI:10.1016/j.clinbiochem.2013.06.013.
[15] Ljuca F, Hadžiefendić B, Jahić E, et al.
Pentraxin 3 might be better prognostic serum marker than IL-6, IL-10, and
high-sensitivity C-reactive protein for major adverse cardiovascular events in
patients with ST-elevation myocardial infarction after bare-metal stent implantation[J].Saudi
Med J,2019,40(12):1202-1208. DOI:10.15537/smj.2019.12.24737.
[16] Cetin MS, Ozcan Cetin EH, Aras D, et al.
Non-O blood groups can be a prognostic marker of in-hospital and long-term
major adverse cardiovascular events in patients with ST elevation myocardial
infarction undergoing primary percutaneous coronary intervention[J].Thromb
Res,2015,136(3):599-605. DOI:10.1016/j.thromres.2015.07.031.
|